News
Circle Biologics® Introduces Innovation in Medical Devices
July 26, 2010 7:35 am | by Bio-Medicine.Org | CommentsMINNEAPOLIS , July 26 /- Circle Biologics®, Inc. has announced a technological break-through in regenerative medicine – its Autologous Platelet Concentrator Platform (APC™). This innovative single device platform is the first of its kind to incorporate both...
Brainlab Offers Real-Time Monitoring for IGRT
July 26, 2010 7:34 am | by Bio-Medicine.Org | CommentsWESTCHESTER, Ill. , July 26 /- Brainlab announced the availability of ExacTrac® Infrared Monitoring, an add-on device to existing treatment machines for monitoring patient positioning during radiation therapy treatments, at the American Association of Physicists in Medicine (AAPM)...
Medical Device Safety Tip: Air or Electric Dermatome Instruments
July 26, 2010 7:31 am | by U.S. Food & Drug Administration | CommentsFDA has received several reports of patients suffering lacerations when undergoing skin grafting procedures with air- or electric-powered Dermatome surgical instruments made by Zimmer, Inc. In one report, the device cut through to the bone and the...
Orthovita gets clearance on collagen facility
July 26, 2010 4:45 am | by The Associated Press | CommentsOrthovita Inc. said Monday it received regulatory approval for a facility where it will process collagen used in Vitagel, a product used to control bleeding during surgery.The company said the Food and Drug Administration cleared a supplement for the new facility, which is located in Malvern,...
Boston Scientific Launches Neuroform EZâ„¢ Stent System in U.S. and Europe
July 26, 2010 4:34 am | by Boston Scientific | CommentsCompany expands market-leading family of neurovascular stents
Onyx Pharmaceuticals Announces Positive Top-Line Carfilzomib Data From Phase 2b Study
July 26, 2010 3:36 am | by Bio-Medicine.Org | CommentsEMERYVILLE, Calif. , July 26 /- Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ) today announced positive top-line results from the Phase 2b 003-A1 study of single-agent carfilzomib, a selective, next generation proteasome inhibitor, in patients with relapsed and refractory multiple myeloma....
Delcath Systems Announces Second Quarter Progress Report Conference Call
July 26, 2010 3:36 am | by Bio-Medicine.Org | CommentsNEW YORK , July 26 /- Delcath Systems, Inc. (Nasdaq: DCTH ) announced today that it will host a conference call to discuss its second quarter results and recent corporate developments on Thursday, July 29, 2010 at 4:30pm, ET . Eamonn Hobbs , President and Chief Executive Officer, and...
Harco Partners With ConMediSys to Deliver Patient Safety and Equipment Integrity
July 26, 2010 3:36 am | by Bio-Medicine.Org | CommentsTEMPE, Ariz. , July 26 /- Harco Metal Products (Harco), an industry leader in tube fabrication, systems integration, and seamless, cost effective manufacturing, announced today the contract to manufacture MediGLIDERâ„¢ products for ConMediSys. ConMediSys, the developer of safety...
Gamma-Tocotrienol Kills Prostate Cancer Stem Cells
July 26, 2010 12:33 am | by Bio-Medicine.Org | CommentsSINGAPORE , July 25 /PRNewswire-Asia/ -- Scientists from Singapore , Australia and Hong Kong have found that gamma-tocotrienol is potent in killing prostate cancer stem cells. This small group of cells is responsible for the initiation of prostate cancer and is resistant to conventional...
2008 U.S. Diabetes Drug Delivery - Patient Perspective
July 26, 2010 12:33 am | by Bio-Medicine.Org | CommentsNEW YORK , July 26 /- Reportlinker.com announces that a new market research report is available in its catalogue: 2008 U.S. Diabetes Drug Delivery - Patient Perspective http://www.reportlinker.com/p0236248/2008-US-Diabetes-Drug-Delivery---Pa... This...
San Diego Businesses Receive Health Care Reform Notices From IRS
July 26, 2010 12:32 am | by San Diego Business Journal | CommentsOne of the first provisions of the Healthcare Reform Act to go into effect may provide relief for many San Diego employers in the form of a small business tax credit designed to assist with the cost of providing health insurance to employees, according to Notice 2010-44 issued by the...
The Marilyn B. Gula Mountains of Hope Foundation donates additional research funds to TGen
July 26, 2010 12:32 am | by EurekAlert | Comments(The Translational Genomics Research Institute) The Marilyn B. Gula Mountains of Hope Foundation continues its fight against advanced breast cancer with a $50,000 donation to the Phoenix-based Translational Genomics Research Institute (TGen), for a total contribution over two years of $300,000.
Heart bypass for uncomplicated heart surgery does not reduce neurocognitive function in children
July 25, 2010 9:33 pm | by EurekAlert | Comments(Children's Hospital of Philadelphia) School-aged children who undergo cardiopulmonary bypass during surgery for less complicated congenital heart defects do not appear to suffer any impairments in neurocognitive abilities, such as intelligence, memory, motor skills and behavior....
Diagnostic 'guidelines' a barrier to prompt relief for some back pain
July 24, 2010 4:34 pm | by EurekAlert | Comments(Johns Hopkins Medical Institutions) Slavishly following long-held guidelines for diagnosing the cause of arthritis-related back pain is resulting in excessive tests, delays in pain relief and wasteful spending of as much as $10,000 per patient, new Johns Hopkins-led research suggests.
Intuitive Surgical expands repurchase(3)
July 23, 2010 4:45 pm | by The Associated Press | CommentsIntuitive Surgical Inc. said Friday that its board authorized the repurchase of an additional $150 million of its stock.The authorization brings the company's amount of stock available for repurchase to $300 million.Shares of the surgical robot maker rose $17.39, or 5.5 percent, to close at...
